Bradley Merrill Thompson, Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in Health Data Management, in “‘21st Century Cures’ Bill Seeks Regulatory Certainty for Health IT” by Greg Slabodkin.
Following is an excerpt:
According to Bradley Merrill Thompson, an attorney at Washington, D.C.-based law firm Epstein Becker Green who counsels medical device companies on regulatory issues, the language in the new SOFTWARE Act bill is quite different from the previous version. “The new legislation in many ways is much more simple and straightforward,” Thompson tells Health Data Management. “It creates a dividing line between software that FDA will regulate and software that should be unregulated. Overall, in my opinion, it's a huge step forward in the sense that it is much clearer and in some ways more focused than the earlier version.”
